Therapeutic Stents Market Report
First published: 21 October 2024 | Last updated: 28 May 2026 | Report Code: therapeutic-stents
Therapeutic Stents Market — USD 7.5 billion in 2023, Growing to USD 14.74B by 2033 at 6.8% CAGR
This report provides an in-depth analysis of the therapeutic stents market, covering market size, trends, segmentation, and forecasts until 2033. Extensive insights are offered on regional performances and the leading companies in the market, facilitating informed decision-making for stakeholders.
Key Takeaways
- Global market expands from $7.50 Billion in 2023 to $14.74 Billion in 2033 at a 6.8% CAGR during 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, moving from $2.76 Billion in 2023 to $5.43 Billion in 2033.
- Europe rises from $2.01 Billion in 2023 to $3.96 Billion in 2033, reflecting steady adoption across healthcare systems.
- Asia Pacific grows from $1.53 Billion in 2023 to $3.01 Billion in 2033, indicating increased procedure volumes and infrastructure investments.
- Segment structure includes product types (drug-eluting, bare metal, bioresorbable), indications, technologies, and end-users for targeted strategies.
Therapeutic Stents Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines market dynamics for therapeutic stents through 2033. Demand is supported by rising cardiovascular conditions and wider acceptance of minimally invasive procedures. Technological advances in drug-eluting and bioresorbable materials, along with regulatory approvals and improved biocompatibility, underlie product innovation. Market sizing shows growth from $7.50 Billion in 2023 to $14.74 Billion in 2033 at a 6.8% CAGR during 2023 to 2033. North America is identified as the largest regional market. The study profiles leading firms such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cordis (a Cardinal Health company), and Terumo Corporation, and breaks the market down by product, indication, technology, and end-user to guide commercial and investment planning.
Key Growth Drivers
- Rising prevalence of cardiovascular disease that increases demand for stent procedures.
- Greater preference for minimally invasive interventions driving procedural volume growth.
- Ongoing improvements in stent materials and drug delivery enhancing clinical outcomes.
- Expanded access to cardiovascular care and infrastructure development in multiple regions.
- Active product development and strategic initiatives by major players including Abbott Laboratories and Medtronic plc.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $7.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $14.74 Billion |
| Top Companies | Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cordis (a Cardinal Health company), Terumo Corporation |
| Published Date | 21 October 2024 |
| Last Modified Date | 28 May 2026 |
Therapeutic Stents Market Overview
Customize Therapeutic Stents Market Report market research report
- ✔ Get in-depth analysis of Therapeutic Stents market size, growth, and forecasts.
- ✔ Understand Therapeutic Stents's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Therapeutic Stents
What is the Market Size & CAGR of Therapeutic Stents Market Report market in 2023?
Therapeutic Stents Industry Analysis
Therapeutic Stents Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Therapeutic Stents Market Report Market Analysis Report by Region
Europe Therapeutic Stents Market Report:
Europe grows from $2.01 Billion in 2023 to $3.96 Billion in 2033. Regional drivers include an aging population, well-developed healthcare systems, and adoption of advanced stent technologies that support expanded treatment of coronary and peripheral artery disease.Asia Pacific Therapeutic Stents Market Report:
Asia Pacific grows from $1.53 Billion in 2023 to $3.01 Billion in 2033. Expansion is driven by improving healthcare infrastructure, greater access to interventional cardiology, and rising incidence of lifestyle-related cardiovascular conditions in several markets.North America Therapeutic Stents Market Report:
North America is largest regional market, rising from $2.76 Billion in 2023 to $5.43 Billion in 2033. This scale reflects high procedural volumes, established clinical adoption of advanced stents, and ongoing innovation by major suppliers in the region.South America Therapeutic Stents Market Report:
Latin America grows from $0.45 Billion in 2023 to $0.88 Billion in 2033. Growth in the region is linked to gradual improvements in healthcare access, increased availability of interventional procedures, and rising awareness of cardiovascular disease management.Middle East & Africa Therapeutic Stents Market Report:
Middle East and Africa grows from $0.75 Billion in 2023 to $1.47 Billion in 2033. Market progress is supported by developing clinical capabilities, investments in cardiovascular services, and growing adoption of minimally invasive treatment options.Tell us your focus area and get a customized research report.
Research Methodology
Therapeutic Stents Market Analysis By Product
The therapeutic stents market by product showcases a robust performance, with drug-eluting stents leading the segment. In 2023, drug-eluting stents are projected to generate a market size of $4.87 billion, increasing to $9.58 billion by 2033, maintaining a market share of 64.96%. Bare-metal stents are valued at $1.51 billion in 2023 and expected to reach $2.97 billion in 2033, capturing a 20.13% market share. Bioresorbable stents, while smaller at $1.12 billion in 2023, are projected to grow to $2.20 billion by 2033, securing a 14.91% market share.
Therapeutic Stents Market Analysis By Indication
By indication, coronary artery disease stands as the dominant segment, valued at $4.87 billion in 2023 and projected to grow to $9.58 billion by 2033, holding a steady 64.96% market share. Peripheral artery disease, on the other hand, is expected to grow from $1.51 billion to $2.97 billion within the same period, capturing 20.13% of the market. Lastly, biliary tract disease begins at $1.12 billion and forecasted to reach $2.20 billion, maintaining a 14.91% share.
Therapeutic Stents Market Analysis By Technology
In terms of technology, balloon-expandable stents are expected to dominate, projected at $6.05 billion in 2023 and growing to $11.89 billion by 2033, holding a market share of 80.69%. Self-expanding stents, in contrast, will start at $1.45 billion in 2023 with anticipated growth to $2.85 billion, representing a 19.31% share of the market.
Therapeutic Stents Market Analysis By End User
The therapeutic stents market by end-user indicates that hospitals are the largest segment, valued at $4.87 billion in 2023 and expected to reach $9.58 billion by 2033, encompassing 64.96% of the market. Clinics are projected to increase from $1.51 billion to $2.97 billion, holding a 20.13% share, while ambulatory surgical centers will grow from $1.12 billion to $2.20 billion, acquiring 14.91% market share.
Therapeutic Stents Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Therapeutic Stents Industry
Abbott Laboratories:
A leader in medical devices, Abbott is renowned for its innovative drug-eluting stents and commitment to advancing healthcare. Their integrated solutions for coronary artery disease significantly enhance patient outcomes.Boston Scientific Corporation:
A global medical device manufacturer, Boston Scientific excels in therapeutic stents, offering a wide range of vascular interventions with a focus on quality and innovation in treatment options.Medtronic plc:
Known for its comprehensive portfolio in cardiovascular medicine, Medtronic is a pivotal player in the therapeutic stents market, contributing advanced technologies to improve vascular therapies.Cordis (a Cardinal Health company):
Cordis is renowned for its innovative endovascular solutions, particularly in the stent market, with a focus on improving procedural efficiency and patient recovery.Terumo Corporation:
A well-established name in the medical field, Terumo is recognized for its high-quality stenting solutions, emphasizing safety and effectiveness in cardiovascular interventions.We're grateful to work with incredible clients.
FAQs
What is the market size of the therapeutic stents market in 2023?
The market size in 2023 is $7.50 Billion as specified in the report data for the Therapeutic Stents Market Report.
How big will the therapeutic stents market be in 2033?
By 2033 the market is reported to reach $14.74 Billion according to the provided forecast figures for the period 2023 to 2033.
What is CAGR for the forecast period?
The compound annual growth rate stated for the forecast period 2023 to 2033 is 6.8% based on the provided market projections.
Is there a single fastest Growing region in the Therapeutic Stents Market Report market?
No single fastest-growing region is stated for the Therapeutic Stents Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which product segments are covered in the segmentation?
Product segmentation includes drug-eluting stents, bare metal stents, and bioresorbable stents as listed among the report’s sub segments.
Who are the leading companies mentioned?
Top companies named in the report are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cordis (a Cardinal Health company), and Terumo Corporation.
What end User categories are included?
End-user sub segments specified include hospitals, clinics, and ambulatory surgical centers as distinct categories in the report.
How was the research conducted?
Research included primary interviews with industry experts and secondary review of company reports and publications, with data triangulation and internal validation.